Food and Drugs Act — F-27 30
s that import them solely for the purpose of export, to maintain any records, reports, electronic data or other documents that the Governor in Council considers necessary for the purposes of this Act; (g) respecting the form and manner of the Minister’s indication under section 12, including the fees payable therefor, and prescribing what premises or what processes or conditions of manufacture, including qualifications of technical staff, shall or shall not be deemed to be suitable for the purposes of that section; (h) requiring manufacturers of any drugs described in Schedule E to submit test portions of any batch of those drugs and respecting the form and manner of the Minister’s indication under section 13, including the fees payable therefor; (h.01) respecting the provision to the Minister of evidence under subsection 16.3 (2); (h.1) respecting the establishment by the Minister of the list referred to in subsection 29.1(1), including amendments to it; (i) respecting the powers, duties and functions of inspectors and analysts and the taking of samples; (i.1) respecting the seizure, detention, forfeiture and disposition of articles under this Act; (j) exempting, with or without conditions, any food, drug, cosmetic, device, person or activity from all or any of the provisions of this Act or the regulations; (j.1) respecting orders referred to in sections 30.01, 30.02, 30.05 and 30.06; (k) prescribing forms for the purposes of this Act and the regulations; (k.1) respecting the time and manner in which information, notices and documents are to be provided or served under this Act; (k.2) requiring persons to provide information to the Minister in respect of food, drugs, cosmetics or devices — or in respect of activities related to food, drugs, cosmetics or devices — in circumstances other than those provided for in this Act and authorizing the Minister to determine the information to be provided and the time and manner in which it is to be provided; (l) providing for the analysis of food, drugs or cosmetics other than for the purposes of this Act and prescribing a tariff of fees to be paid for that analysis; (l.1) respecting the assessment of the effect on the environment or on human life and health of the release into the environment of any food, drug, cosmetic or device, and the measures to take before importing or selling any such food, drug, cosmetic or device; (m) adding anything to any of the schedules, other than to Schedule A or G, in the interest of, or for the prevention of injury to, the health of the purchaser or consumer, or deleting anything from any of the schedules, other than from Schedule A or G; (n) respecting the distribution or the conditions of distribution of drugs as samples; (o) respecting (i) the method of manufacture, preparation, preserving, packing, labelling, storing and testing of any new drug, and (ii) the sale or the conditions of sale of any new drug, and defining for the purposes of this Act the expression new drug ; (p) authorizing the advertising to the general public of contraceptive devices and drugs manufactured, sold or represented for use in the prevention of conception and prescribing the circumstances and conditions under which, and the persons by whom, those devices and drugs may be so advertised; (q) defining agricultural chemical , food additive , mineral nutrient , veterinary drug and vitamin for the purposes of this Act; (r) [Repealed, 2024, c. 17, s. 325] (s) respecting the implementation, in relation to any food, drug, cosmetic or device, of international agreements that affect them; and (t) prescribing anything that by this Act is to be prescribed. Classes (1.1) A regulation made under this Act may establish classes and distinguish among those classes. Regulations — therapeutic products (1.2) Without limiting the power conferred by any other subsection of this section, the Governor in Council may make regulations (a) respecting the issuance of authorizations — including licence